09 May 2018 Research

Sharing this exciting news: a treatment advance for childhood leukaemia

A deal has been struck to let the NHS offer children an expensive new cancer therapy that has been called the most exciting treatment advance for decades.

“We are excited at this breakthrough in the treatment for childhood leukaemia. CAR-T cell therapy gives those children who do not respond to chemotherapy treatment a real chance of a long-term cure. We welcome this significant step forward which will give hope to families whose children are affected by leukaemia.” 

Dr Maria Gilleece, Director, Yorkshire Blood and Marrow Transplant Programme and a member of the Leukaemia UK Medical Panel.

Follow this link to read this BBC news story.

Leukaemia Care and Leukaemia UK join forces with funky feathered friend to make disease symptoms more memorable

25 August 2022

Leukaemia Care and Leukaemia UK join forces with funky feathered friend to make disease symptoms more memorable

The two leading UK leukaemia charities have launched a collaboration today with a difference. They’ve joined forces with a blue and gold Macaw parrot called Henry to create an original…

Charities call on NHS to treat blood cancer equally in decision-making

16 November 2021

Charities call on NHS to treat blood cancer equally in decision-making

The Blood Cancer Alliance undertook an evidence review to inform a new report exploring the unmet needs of people with blood cancer across the UK.

Prestigious jointly-funded fellowship could be catalyst for myeloma prevention

21 June 2023

Prestigious jointly-funded fellowship could be catalyst for myeloma prevention

Dr Louise Ainley, University College London, has been awarded a Clinical Research Training Fellowship – jointly funded with the Medical Research Council. The three-year project is set to investigate which…

A new clinical trial announced

21 May 2020

A new clinical trial announced

A study into the impact of severe covid-19 infection on patients who receive stem cell transplants for blood cancers and blood disorders.